ReviewTopics in current chemistry (Cham)2025
Applications of Olefin Metathesis in the Synthesis of Fluorinated Substrates and Design of Fluorinated Catalysts.
Review in Topics in current chemistry (Cham), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a result of the high pharmaceutical relevance of organofluorine compounds in drug discovery, the synthetic approach towards this class of derivatives has generated increasing interest in organic chemistry over the past decade. Metathesis, with the manipulation of the C = C double bonds, is considered to be a powerful tool in preparative organic chemistry to access various sophisticated and densely functionalized scaffolds with olefin bonds in their structure. The current paper is intended to describe, investigate, and analyze the most impactful advances and applications of metathesis with organofluorine molecular entities achieved since the outstanding review by Fustero, Haufe and others (Chem. Rev. 2015, 115, 871 - 930, dx.doi.org/10.1021/cr500182a) published a decade ago.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.